nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP2C9—Donepezil—Alzheimer's disease	0.111	1	CbGbCtD
Agomelatine—HTR2C—choroid plexus—Alzheimer's disease	0.0622	0.35	CbGeAlD
Agomelatine—MTNR1A—forebrain—Alzheimer's disease	0.0194	0.109	CbGeAlD
Agomelatine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.0182	0.102	CbGeAlD
Agomelatine—MTNR1A—telencephalon—Alzheimer's disease	0.0179	0.1	CbGeAlD
Agomelatine—Restless legs syndrome—Rivastigmine—Alzheimer's disease	0.0153	0.0329	CcSEcCtD
Agomelatine—MTNR1A—nervous system—Alzheimer's disease	0.0106	0.0593	CbGeAlD
Agomelatine—MTNR1A—central nervous system—Alzheimer's disease	0.0102	0.0571	CbGeAlD
Agomelatine—Suicidal ideation—Galantamine—Alzheimer's disease	0.00905	0.0195	CcSEcCtD
Agomelatine—MTNR1A—brain—Alzheimer's disease	0.00807	0.0453	CbGeAlD
Agomelatine—Aggression—Galantamine—Alzheimer's disease	0.00722	0.0156	CcSEcCtD
Agomelatine—Suicidal ideation—Memantine—Alzheimer's disease	0.00637	0.0137	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Galantamine—Alzheimer's disease	0.00635	0.0137	CcSEcCtD
Agomelatine—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.00623	0.0134	CcSEcCtD
Agomelatine—Mania—Memantine—Alzheimer's disease	0.00614	0.0132	CcSEcCtD
Agomelatine—Nightmare—Galantamine—Alzheimer's disease	0.00613	0.0132	CcSEcCtD
Agomelatine—Rash erythematous—Memantine—Alzheimer's disease	0.00583	0.0126	CcSEcCtD
Agomelatine—Rash erythematous—Rivastigmine—Alzheimer's disease	0.00571	0.0123	CcSEcCtD
Agomelatine—Aggression—Donepezil—Alzheimer's disease	0.0056	0.0121	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Galantamine—Alzheimer's disease	0.0053	0.0114	CcSEcCtD
Agomelatine—Aggression—Memantine—Alzheimer's disease	0.00508	0.011	CcSEcCtD
Agomelatine—Aggression—Rivastigmine—Alzheimer's disease	0.00497	0.0107	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Donepezil—Alzheimer's disease	0.00492	0.0106	CcSEcCtD
Agomelatine—Abnormal dreams—Donepezil—Alzheimer's disease	0.00486	0.0105	CcSEcCtD
Agomelatine—HTR2C—forebrain—Alzheimer's disease	0.00476	0.0268	CbGeAlD
Agomelatine—HTR2B—forebrain—Alzheimer's disease	0.00447	0.0251	CbGeAlD
Agomelatine—Phosphatase alkaline increased—Memantine—Alzheimer's disease	0.00447	0.00962	CcSEcCtD
Agomelatine—HTR2C—telencephalon—Alzheimer's disease	0.00438	0.0246	CbGeAlD
Agomelatine—Phosphatase alkaline increased—Rivastigmine—Alzheimer's disease	0.00437	0.00942	CcSEcCtD
Agomelatine—Melatonin—MT3—Alzheimer's disease	0.00434	0.218	CrCbGaD
Agomelatine—Nightmare—Memantine—Alzheimer's disease	0.00431	0.00929	CcSEcCtD
Agomelatine—Nightmare—Rivastigmine—Alzheimer's disease	0.00422	0.00909	CcSEcCtD
Agomelatine—HTR2B—telencephalon—Alzheimer's disease	0.00411	0.0231	CbGeAlD
Agomelatine—Blood alkaline phosphatase increased—Donepezil—Alzheimer's disease	0.00411	0.00885	CcSEcCtD
Agomelatine—Eczema—Donepezil—Alzheimer's disease	0.00397	0.00856	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.00373	0.00803	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.00365	0.00786	CcSEcCtD
Agomelatine—Hepatic failure—Memantine—Alzheimer's disease	0.00361	0.00777	CcSEcCtD
Agomelatine—Eczema—Memantine—Alzheimer's disease	0.00361	0.00777	CcSEcCtD
Agomelatine—Weight decreased—Galantamine—Alzheimer's disease	0.0036	0.00776	CcSEcCtD
Agomelatine—Depression—Galantamine—Alzheimer's disease	0.00354	0.00763	CcSEcCtD
Agomelatine—Eczema—Rivastigmine—Alzheimer's disease	0.00353	0.00761	CcSEcCtD
Agomelatine—Face oedema—Donepezil—Alzheimer's disease	0.00345	0.00743	CcSEcCtD
Agomelatine—Irritability—Donepezil—Alzheimer's disease	0.00341	0.00734	CcSEcCtD
Agomelatine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00336	0.00724	CcSEcCtD
Agomelatine—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00319	0.00688	CcSEcCtD
Agomelatine—Hepatitis—Galantamine—Alzheimer's disease	0.00319	0.00687	CcSEcCtD
Agomelatine—Hallucination—Galantamine—Alzheimer's disease	0.00317	0.00683	CcSEcCtD
Agomelatine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00313	0.00675	CcSEcCtD
Agomelatine—Migraine—Rivastigmine—Alzheimer's disease	0.00312	0.00673	CcSEcCtD
Agomelatine—Irritability—Memantine—Alzheimer's disease	0.00309	0.00667	CcSEcCtD
Agomelatine—Influenza—Donepezil—Alzheimer's disease	0.00309	0.00665	CcSEcCtD
Agomelatine—Face oedema—Rivastigmine—Alzheimer's disease	0.00306	0.0066	CcSEcCtD
Agomelatine—Eye disorder—Galantamine—Alzheimer's disease	0.00298	0.00642	CcSEcCtD
Agomelatine—Tinnitus—Galantamine—Alzheimer's disease	0.00297	0.0064	CcSEcCtD
Agomelatine—Nasopharyngitis—Memantine—Alzheimer's disease	0.0029	0.00625	CcSEcCtD
Agomelatine—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00284	0.00611	CcSEcCtD
Agomelatine—Nabumetone—MPO—Alzheimer's disease	0.00282	0.142	CrCbGaD
Agomelatine—Weight increased—Donepezil—Alzheimer's disease	0.00281	0.00605	CcSEcCtD
Agomelatine—Influenza—Memantine—Alzheimer's disease	0.0028	0.00604	CcSEcCtD
Agomelatine—Mental disorder—Galantamine—Alzheimer's disease	0.00279	0.00602	CcSEcCtD
Agomelatine—Weight decreased—Donepezil—Alzheimer's disease	0.00279	0.00602	CcSEcCtD
Agomelatine—Infestation NOS—Donepezil—Alzheimer's disease	0.00275	0.00593	CcSEcCtD
Agomelatine—Infestation—Donepezil—Alzheimer's disease	0.00275	0.00593	CcSEcCtD
Agomelatine—Depression—Donepezil—Alzheimer's disease	0.00274	0.00591	CcSEcCtD
Agomelatine—Back pain—Galantamine—Alzheimer's disease	0.00268	0.00578	CcSEcCtD
Agomelatine—Jaundice—Donepezil—Alzheimer's disease	0.00268	0.00578	CcSEcCtD
Agomelatine—Vision blurred—Galantamine—Alzheimer's disease	0.00261	0.00563	CcSEcCtD
Agomelatine—Tremor—Galantamine—Alzheimer's disease	0.0026	0.0056	CcSEcCtD
Agomelatine—HTR2C—nervous system—Alzheimer's disease	0.00258	0.0145	CbGeAlD
Agomelatine—Weight increased—Memantine—Alzheimer's disease	0.00255	0.0055	CcSEcCtD
Agomelatine—Agitation—Galantamine—Alzheimer's disease	0.00255	0.00549	CcSEcCtD
Agomelatine—Weight decreased—Memantine—Alzheimer's disease	0.00254	0.00546	CcSEcCtD
Agomelatine—Infestation NOS—Memantine—Alzheimer's disease	0.0025	0.00538	CcSEcCtD
Agomelatine—Infestation—Memantine—Alzheimer's disease	0.0025	0.00538	CcSEcCtD
Agomelatine—Weight increased—Rivastigmine—Alzheimer's disease	0.00249	0.00538	CcSEcCtD
Agomelatine—Vertigo—Galantamine—Alzheimer's disease	0.00249	0.00537	CcSEcCtD
Agomelatine—Depression—Memantine—Alzheimer's disease	0.00249	0.00537	CcSEcCtD
Agomelatine—HTR2C—central nervous system—Alzheimer's disease	0.00249	0.014	CbGeAlD
Agomelatine—Weight decreased—Rivastigmine—Alzheimer's disease	0.00248	0.00534	CcSEcCtD
Agomelatine—Hepatitis—Donepezil—Alzheimer's disease	0.00247	0.00532	CcSEcCtD
Agomelatine—Hallucination—Donepezil—Alzheimer's disease	0.00246	0.0053	CcSEcCtD
Agomelatine—Infestation—Rivastigmine—Alzheimer's disease	0.00244	0.00527	CcSEcCtD
Agomelatine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00244	0.00527	CcSEcCtD
Agomelatine—Depression—Rivastigmine—Alzheimer's disease	0.00244	0.00525	CcSEcCtD
Agomelatine—HTR2B—nervous system—Alzheimer's disease	0.00243	0.0136	CbGeAlD
Agomelatine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00236	0.00509	CcSEcCtD
Agomelatine—Anxiety—Galantamine—Alzheimer's disease	0.00235	0.00507	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00235	0.00506	CcSEcCtD
Agomelatine—HTR2B—central nervous system—Alzheimer's disease	0.00234	0.0131	CbGeAlD
Agomelatine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00231	0.00498	CcSEcCtD
Agomelatine—Dry mouth—Galantamine—Alzheimer's disease	0.00231	0.00498	CcSEcCtD
Agomelatine—Tinnitus—Donepezil—Alzheimer's disease	0.0023	0.00496	CcSEcCtD
Agomelatine—Hepatitis—Memantine—Alzheimer's disease	0.00224	0.00483	CcSEcCtD
Agomelatine—Hallucination—Memantine—Alzheimer's disease	0.00223	0.00481	CcSEcCtD
Agomelatine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00222	0.00479	CcSEcCtD
Agomelatine—Connective tissue disorder—Memantine—Alzheimer's disease	0.0022	0.00475	CcSEcCtD
Agomelatine—Skin disorder—Galantamine—Alzheimer's disease	0.0022	0.00474	CcSEcCtD
Agomelatine—Hepatitis—Rivastigmine—Alzheimer's disease	0.00219	0.00473	CcSEcCtD
Agomelatine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00219	0.00472	CcSEcCtD
Agomelatine—Hallucination—Rivastigmine—Alzheimer's disease	0.00218	0.0047	CcSEcCtD
Agomelatine—Mental disorder—Donepezil—Alzheimer's disease	0.00216	0.00466	CcSEcCtD
Agomelatine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00216	0.00465	CcSEcCtD
Agomelatine—Eye disorder—Memantine—Alzheimer's disease	0.0021	0.00452	CcSEcCtD
Agomelatine—Tinnitus—Memantine—Alzheimer's disease	0.00209	0.00451	CcSEcCtD
Agomelatine—Back pain—Donepezil—Alzheimer's disease	0.00208	0.00448	CcSEcCtD
Agomelatine—Melatonin—CALM1—Alzheimer's disease	0.00207	0.104	CrCbGaD
Agomelatine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00205	0.00442	CcSEcCtD
Agomelatine—Insomnia—Galantamine—Alzheimer's disease	0.00205	0.00441	CcSEcCtD
Agomelatine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00205	0.00441	CcSEcCtD
Agomelatine—Paraesthesia—Galantamine—Alzheimer's disease	0.00203	0.00438	CcSEcCtD
Agomelatine—Vision blurred—Donepezil—Alzheimer's disease	0.00203	0.00437	CcSEcCtD
Agomelatine—Tremor—Donepezil—Alzheimer's disease	0.00201	0.00434	CcSEcCtD
Agomelatine—Somnolence—Galantamine—Alzheimer's disease	0.00201	0.00434	CcSEcCtD
Agomelatine—Dyspepsia—Galantamine—Alzheimer's disease	0.00199	0.0043	CcSEcCtD
Agomelatine—Agitation—Donepezil—Alzheimer's disease	0.00198	0.00426	CcSEcCtD
Agomelatine—HTR2C—brain—Alzheimer's disease	0.00198	0.0111	CbGeAlD
Agomelatine—Mental disorder—Memantine—Alzheimer's disease	0.00196	0.00423	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00196	0.00421	CcSEcCtD
Agomelatine—Fatigue—Galantamine—Alzheimer's disease	0.00195	0.00421	CcSEcCtD
Agomelatine—Constipation—Galantamine—Alzheimer's disease	0.00194	0.00417	CcSEcCtD
Agomelatine—Vertigo—Donepezil—Alzheimer's disease	0.00193	0.00416	CcSEcCtD
Agomelatine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00192	0.00414	CcSEcCtD
Agomelatine—Back pain—Memantine—Alzheimer's disease	0.00189	0.00407	CcSEcCtD
Agomelatine—HTR2B—brain—Alzheimer's disease	0.00186	0.0104	CbGeAlD
Agomelatine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00185	0.00399	CcSEcCtD
Agomelatine—Nabumetone—PTGS1—Alzheimer's disease	0.00185	0.0929	CrCbGaD
Agomelatine—Back pain—Rivastigmine—Alzheimer's disease	0.00185	0.00398	CcSEcCtD
Agomelatine—Vision blurred—Memantine—Alzheimer's disease	0.00184	0.00397	CcSEcCtD
Agomelatine—Tremor—Memantine—Alzheimer's disease	0.00183	0.00394	CcSEcCtD
Agomelatine—Anxiety—Donepezil—Alzheimer's disease	0.00182	0.00393	CcSEcCtD
Agomelatine—Vision blurred—Rivastigmine—Alzheimer's disease	0.0018	0.00388	CcSEcCtD
Agomelatine—Agitation—Memantine—Alzheimer's disease	0.00179	0.00387	CcSEcCtD
Agomelatine—Dry mouth—Donepezil—Alzheimer's disease	0.00179	0.00386	CcSEcCtD
Agomelatine—Abdominal pain—Galantamine—Alzheimer's disease	0.00179	0.00386	CcSEcCtD
Agomelatine—Tremor—Rivastigmine—Alzheimer's disease	0.00179	0.00386	CcSEcCtD
Agomelatine—Agitation—Rivastigmine—Alzheimer's disease	0.00176	0.00378	CcSEcCtD
Agomelatine—Vertigo—Memantine—Alzheimer's disease	0.00175	0.00378	CcSEcCtD
Agomelatine—Infection—Donepezil—Alzheimer's disease	0.00174	0.00376	CcSEcCtD
Agomelatine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00172	0.00371	CcSEcCtD
Agomelatine—Vertigo—Rivastigmine—Alzheimer's disease	0.00172	0.0037	CcSEcCtD
Agomelatine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.0017	0.00366	CcSEcCtD
Agomelatine—Anxiety—Memantine—Alzheimer's disease	0.00166	0.00357	CcSEcCtD
Agomelatine—Dry mouth—Memantine—Alzheimer's disease	0.00163	0.0035	CcSEcCtD
Agomelatine—Asthenia—Galantamine—Alzheimer's disease	0.00162	0.0035	CcSEcCtD
Agomelatine—Anxiety—Rivastigmine—Alzheimer's disease	0.00162	0.00349	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00161	0.00348	CcSEcCtD
Agomelatine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00159	0.00343	CcSEcCtD
Agomelatine—Insomnia—Donepezil—Alzheimer's disease	0.00159	0.00342	CcSEcCtD
Agomelatine—Infection—Memantine—Alzheimer's disease	0.00158	0.00341	CcSEcCtD
Agomelatine—Paraesthesia—Donepezil—Alzheimer's disease	0.00158	0.0034	CcSEcCtD
Agomelatine—Nervous system disorder—Memantine—Alzheimer's disease	0.00156	0.00337	CcSEcCtD
Agomelatine—Somnolence—Donepezil—Alzheimer's disease	0.00156	0.00336	CcSEcCtD
Agomelatine—Diarrhoea—Galantamine—Alzheimer's disease	0.00155	0.00334	CcSEcCtD
Agomelatine—Infection—Rivastigmine—Alzheimer's disease	0.00155	0.00334	CcSEcCtD
Agomelatine—Skin disorder—Memantine—Alzheimer's disease	0.00155	0.00334	CcSEcCtD
Agomelatine—Dyspepsia—Donepezil—Alzheimer's disease	0.00154	0.00333	CcSEcCtD
Agomelatine—Hyperhidrosis—Memantine—Alzheimer's disease	0.00154	0.00332	CcSEcCtD
Agomelatine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00153	0.00329	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00152	0.00326	CcSEcCtD
Agomelatine—Skin disorder—Rivastigmine—Alzheimer's disease	0.00151	0.00326	CcSEcCtD
Agomelatine—Fatigue—Donepezil—Alzheimer's disease	0.00151	0.00326	CcSEcCtD
Agomelatine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00151	0.00325	CcSEcCtD
Agomelatine—Constipation—Donepezil—Alzheimer's disease	0.0015	0.00323	CcSEcCtD
Agomelatine—Dizziness—Galantamine—Alzheimer's disease	0.0015	0.00323	CcSEcCtD
Agomelatine—Insomnia—Memantine—Alzheimer's disease	0.00144	0.00311	CcSEcCtD
Agomelatine—Vomiting—Galantamine—Alzheimer's disease	0.00144	0.0031	CcSEcCtD
Agomelatine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00144	0.00309	CcSEcCtD
Agomelatine—Paraesthesia—Memantine—Alzheimer's disease	0.00143	0.00308	CcSEcCtD
Agomelatine—Headache—Galantamine—Alzheimer's disease	0.00142	0.00306	CcSEcCtD
Agomelatine—Somnolence—Memantine—Alzheimer's disease	0.00142	0.00305	CcSEcCtD
Agomelatine—Insomnia—Rivastigmine—Alzheimer's disease	0.00141	0.00304	CcSEcCtD
Agomelatine—Dyspepsia—Memantine—Alzheimer's disease	0.0014	0.00302	CcSEcCtD
Agomelatine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.0014	0.00302	CcSEcCtD
Agomelatine—Urticaria—Donepezil—Alzheimer's disease	0.00139	0.003	CcSEcCtD
Agomelatine—Abdominal pain—Donepezil—Alzheimer's disease	0.00139	0.00299	CcSEcCtD
Agomelatine—Somnolence—Rivastigmine—Alzheimer's disease	0.00139	0.00299	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00138	0.00296	CcSEcCtD
Agomelatine—Fatigue—Memantine—Alzheimer's disease	0.00137	0.00296	CcSEcCtD
Agomelatine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00137	0.00296	CcSEcCtD
Agomelatine—Constipation—Memantine—Alzheimer's disease	0.00136	0.00294	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00135	0.0029	CcSEcCtD
Agomelatine—Nausea—Galantamine—Alzheimer's disease	0.00135	0.0029	CcSEcCtD
Agomelatine—Fatigue—Rivastigmine—Alzheimer's disease	0.00134	0.0029	CcSEcCtD
Agomelatine—Constipation—Rivastigmine—Alzheimer's disease	0.00133	0.00287	CcSEcCtD
Agomelatine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.0013	0.00281	CcSEcCtD
Agomelatine—Midodrine—CYP2D6—Alzheimer's disease	0.00129	0.0649	CrCbGaD
Agomelatine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00127	0.00275	CcSEcCtD
Agomelatine—Urticaria—Memantine—Alzheimer's disease	0.00127	0.00273	CcSEcCtD
Agomelatine—Abdominal pain—Memantine—Alzheimer's disease	0.00126	0.00271	CcSEcCtD
Agomelatine—Asthenia—Donepezil—Alzheimer's disease	0.00126	0.00271	CcSEcCtD
Agomelatine—Pruritus—Donepezil—Alzheimer's disease	0.00124	0.00268	CcSEcCtD
Agomelatine—Urticaria—Rivastigmine—Alzheimer's disease	0.00124	0.00267	CcSEcCtD
Agomelatine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00123	0.00266	CcSEcCtD
Agomelatine—Diarrhoea—Donepezil—Alzheimer's disease	0.0012	0.00259	CcSEcCtD
Agomelatine—Dizziness—Donepezil—Alzheimer's disease	0.00116	0.0025	CcSEcCtD
Agomelatine—Encainide—CYP2D6—Alzheimer's disease	0.00115	0.0578	CrCbGaD
Agomelatine—Asthenia—Memantine—Alzheimer's disease	0.00114	0.00246	CcSEcCtD
Agomelatine—Pruritus—Memantine—Alzheimer's disease	0.00113	0.00243	CcSEcCtD
Agomelatine—Melatonin—MPO—Alzheimer's disease	0.00112	0.0564	CrCbGaD
Agomelatine—Asthenia—Rivastigmine—Alzheimer's disease	0.00112	0.00241	CcSEcCtD
Agomelatine—Vomiting—Donepezil—Alzheimer's disease	0.00112	0.0024	CcSEcCtD
Agomelatine—Pruritus—Rivastigmine—Alzheimer's disease	0.0011	0.00238	CcSEcCtD
Agomelatine—Headache—Donepezil—Alzheimer's disease	0.0011	0.00237	CcSEcCtD
Agomelatine—Diarrhoea—Memantine—Alzheimer's disease	0.00109	0.00235	CcSEcCtD
Agomelatine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00107	0.0023	CcSEcCtD
Agomelatine—Nabumetone—PTGS2—Alzheimer's disease	0.00106	0.0531	CrCbGaD
Agomelatine—Dizziness—Memantine—Alzheimer's disease	0.00105	0.00227	CcSEcCtD
Agomelatine—Nausea—Donepezil—Alzheimer's disease	0.00104	0.00225	CcSEcCtD
Agomelatine—Dizziness—Rivastigmine—Alzheimer's disease	0.00103	0.00222	CcSEcCtD
Agomelatine—Vomiting—Memantine—Alzheimer's disease	0.00101	0.00218	CcSEcCtD
Agomelatine—Headache—Memantine—Alzheimer's disease	0.000998	0.00215	CcSEcCtD
Agomelatine—Vomiting—Rivastigmine—Alzheimer's disease	0.000991	0.00214	CcSEcCtD
Agomelatine—Headache—Rivastigmine—Alzheimer's disease	0.000977	0.0021	CcSEcCtD
Agomelatine—Nausea—Memantine—Alzheimer's disease	0.000946	0.00204	CcSEcCtD
Agomelatine—Indomethacin—PPARG—Alzheimer's disease	0.000939	0.0472	CrCbGaD
Agomelatine—Nausea—Rivastigmine—Alzheimer's disease	0.000926	0.002	CcSEcCtD
Agomelatine—Naproxen—PTGS1—Alzheimer's disease	0.000856	0.043	CrCbGaD
Agomelatine—Melatonin—ESR1—Alzheimer's disease	0.000843	0.0423	CrCbGaD
Agomelatine—Indomethacin—PTGS1—Alzheimer's disease	0.000694	0.0348	CrCbGaD
Agomelatine—Naproxen—PTGS2—Alzheimer's disease	0.000489	0.0246	CrCbGaD
Agomelatine—Indomethacin—PTGS2—Alzheimer's disease	0.000397	0.0199	CrCbGaD
Agomelatine—HTR2C—GPCR downstream signaling—APP—Alzheimer's disease	8.96e-05	0.000394	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	8.94e-05	0.000393	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GAL—Alzheimer's disease	8.92e-05	0.000393	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GFAP—Alzheimer's disease	8.92e-05	0.000393	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CA4—Alzheimer's disease	8.89e-05	0.000391	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—NPS—Alzheimer's disease	8.75e-05	0.000385	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PPP3CA—Alzheimer's disease	8.71e-05	0.000383	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	8.69e-05	0.000383	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR6—Alzheimer's disease	8.66e-05	0.000381	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PLCB1—Alzheimer's disease	8.45e-05	0.000372	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	8.36e-05	0.000368	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—SST—Alzheimer's disease	8.35e-05	0.000367	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GAB2—Alzheimer's disease	8.35e-05	0.000367	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.33e-05	0.000367	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOS3—Alzheimer's disease	8.32e-05	0.000366	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOS3—Alzheimer's disease	8.32e-05	0.000366	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—APP—Alzheimer's disease	8.14e-05	0.000358	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL2—Alzheimer's disease	8.02e-05	0.000353	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	7.93e-05	0.000349	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PSENEN—Alzheimer's disease	7.87e-05	0.000346	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—A2M—Alzheimer's disease	7.86e-05	0.000346	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	7.83e-05	0.000344	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APH1A—Alzheimer's disease	7.76e-05	0.000341	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.75e-05	0.000341	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PLCB1—Alzheimer's disease	7.68e-05	0.000338	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PSEN2—Alzheimer's disease	7.61e-05	0.000335	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CA4—Alzheimer's disease	7.6e-05	0.000334	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLD3—Alzheimer's disease	7.56e-05	0.000333	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	7.56e-05	0.000333	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NCSTN—Alzheimer's disease	7.55e-05	0.000332	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	7.47e-05	0.000329	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.43e-05	0.000327	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LRP1—Alzheimer's disease	7.37e-05	0.000324	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCR5—Alzheimer's disease	7.34e-05	0.000323	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	7.25e-05	0.000319	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GFAP—Alzheimer's disease	7.2e-05	0.000317	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GAL—Alzheimer's disease	7.2e-05	0.000317	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.19e-05	0.000316	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	7.14e-05	0.000314	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	7.13e-05	0.000314	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	7.13e-05	0.000314	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.09e-05	0.000312	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CASP3—Alzheimer's disease	7.06e-05	0.000311	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CASP3—Alzheimer's disease	7.06e-05	0.000311	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PRKCG—Alzheimer's disease	7.04e-05	0.00031	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—Alzheimer's disease	7.02e-05	0.000309	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—Alzheimer's disease	7.02e-05	0.000309	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NPY—Alzheimer's disease	7.01e-05	0.000308	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	6.98e-05	0.000307	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IAPP—Alzheimer's disease	6.96e-05	0.000306	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	6.77e-05	0.000298	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CRH—Alzheimer's disease	6.76e-05	0.000298	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ND1—Alzheimer's disease	6.74e-05	0.000297	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR5—Alzheimer's disease	6.67e-05	0.000293	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.59e-05	0.00029	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2A—Alzheimer's disease	6.53e-05	0.000287	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK8—Alzheimer's disease	6.49e-05	0.000286	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK8—Alzheimer's disease	6.49e-05	0.000286	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AKT1—Alzheimer's disease	6.47e-05	0.000285	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AKT1—Alzheimer's disease	6.47e-05	0.000285	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLD3—Alzheimer's disease	6.46e-05	0.000284	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.46e-05	0.000284	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NPS—Alzheimer's disease	6.41e-05	0.000282	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.39e-05	0.000281	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PPP3CA—Alzheimer's disease	6.38e-05	0.000281	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—A2M—Alzheimer's disease	6.34e-05	0.000279	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	6.31e-05	0.000278	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—F2—Alzheimer's disease	6.3e-05	0.000277	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTK2B—Alzheimer's disease	6.28e-05	0.000277	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PRKCG—Alzheimer's disease	6.25e-05	0.000275	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	6.19e-05	0.000273	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PSEN2—Alzheimer's disease	6.14e-05	0.00027	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GAB2—Alzheimer's disease	6.11e-05	0.000269	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SST—Alzheimer's disease	6.11e-05	0.000269	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NTRK2—Alzheimer's disease	6.11e-05	0.000269	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CALM1—Alzheimer's disease	6.09e-05	0.000268	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GSK3A—Alzheimer's disease	6.06e-05	0.000267	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.05e-05	0.000266	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.02e-05	0.000265	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—Alzheimer's disease	5.99e-05	0.000264	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—Alzheimer's disease	5.99e-05	0.000264	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	5.96e-05	0.000262	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APP—Alzheimer's disease	5.96e-05	0.000262	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR5—Alzheimer's disease	5.92e-05	0.000261	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.8e-05	0.000255	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ND1—Alzheimer's disease	5.76e-05	0.000253	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—F2—Alzheimer's disease	5.72e-05	0.000252	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PRKCG—Alzheimer's disease	5.68e-05	0.00025	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NPY—Alzheimer's disease	5.65e-05	0.000249	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.63e-05	0.000248	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PLCB1—Alzheimer's disease	5.62e-05	0.000247	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IAPP—Alzheimer's disease	5.62e-05	0.000247	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFB1—Alzheimer's disease	5.5e-05	0.000242	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFB1—Alzheimer's disease	5.5e-05	0.000242	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CRH—Alzheimer's disease	5.45e-05	0.00024	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR5—Alzheimer's disease	5.38e-05	0.000237	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR2A—Alzheimer's disease	5.26e-05	0.000232	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NGFR—Alzheimer's disease	5.24e-05	0.000231	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CREB1—Alzheimer's disease	5.21e-05	0.000229	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.19e-05	0.000229	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NPS—Alzheimer's disease	5.17e-05	0.000228	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.15e-05	0.000227	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PPP3CA—Alzheimer's disease	5.14e-05	0.000226	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADAM10—Alzheimer's disease	5.12e-05	0.000225	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL2—Alzheimer's disease	5.1e-05	0.000224	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—F2—Alzheimer's disease	5.08e-05	0.000224	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTK2B—Alzheimer's disease	5.07e-05	0.000223	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SST—Alzheimer's disease	4.93e-05	0.000217	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NTRK2—Alzheimer's disease	4.93e-05	0.000217	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GAB2—Alzheimer's disease	4.93e-05	0.000217	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CALM1—Alzheimer's disease	4.91e-05	0.000216	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GSK3A—Alzheimer's disease	4.89e-05	0.000215	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—S100B—Alzheimer's disease	4.84e-05	0.000213	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APP—Alzheimer's disease	4.81e-05	0.000212	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.73e-05	0.000208	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—F2—Alzheimer's disease	4.62e-05	0.000203	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF2—Alzheimer's disease	4.61e-05	0.000203	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PLCB1—Alzheimer's disease	4.54e-05	0.0002	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—Alzheimer's disease	4.53e-05	0.000199	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—Alzheimer's disease	4.53e-05	0.000199	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1R—Alzheimer's disease	4.46e-05	0.000196	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.44e-05	0.000195	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	4.34e-05	0.000191	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	4.34e-05	0.000191	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LPL—Alzheimer's disease	4.28e-05	0.000188	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MEF2C—Alzheimer's disease	4.24e-05	0.000186	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NGFR—Alzheimer's disease	4.23e-05	0.000186	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CREB1—Alzheimer's disease	4.2e-05	0.000185	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	4.16e-05	0.000183	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRKCG—Alzheimer's disease	4.16e-05	0.000183	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—Alzheimer's disease	4.14e-05	0.000182	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—Alzheimer's disease	4.14e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADAM10—Alzheimer's disease	4.13e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL2—Alzheimer's disease	4.11e-05	0.000181	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NGF—Alzheimer's disease	4.05e-05	0.000178	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.04e-05	0.000178	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	4.01e-05	0.000176	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.96e-05	0.000174	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR5—Alzheimer's disease	3.94e-05	0.000173	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.93e-05	0.000173	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—S100B—Alzheimer's disease	3.91e-05	0.000172	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—A2M—Alzheimer's disease	3.87e-05	0.00017	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—Alzheimer's disease	3.86e-05	0.00017	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—Alzheimer's disease	3.82e-05	0.000168	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—Alzheimer's disease	3.82e-05	0.000168	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF2—Alzheimer's disease	3.72e-05	0.000164	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	3.71e-05	0.000163	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	3.71e-05	0.000163	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1R—Alzheimer's disease	3.6e-05	0.000158	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CALM1—Alzheimer's disease	3.6e-05	0.000158	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—Alzheimer's disease	3.58e-05	0.000158	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LEP—Alzheimer's disease	3.58e-05	0.000158	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	3.56e-05	0.000157	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CAV1—Alzheimer's disease	3.55e-05	0.000156	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.45e-05	0.000152	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LPL—Alzheimer's disease	3.45e-05	0.000152	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	3.42e-05	0.000151	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ESR1—Alzheimer's disease	3.42e-05	0.000151	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MEF2C—Alzheimer's disease	3.42e-05	0.00015	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.39e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—F2—Alzheimer's disease	3.38e-05	0.000149	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	3.37e-05	0.000148	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.36e-05	0.000148	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	3.35e-05	0.000148	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	3.33e-05	0.000146	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—A2M—Alzheimer's disease	3.31e-05	0.000146	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.31e-05	0.000146	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	3.27e-05	0.000144	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	3.18e-05	0.00014	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.16e-05	0.000139	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.16e-05	0.000139	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	3.11e-05	0.000137	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GSK3B—Alzheimer's disease	3.1e-05	0.000137	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	3.09e-05	0.000136	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CREB1—Alzheimer's disease	3.08e-05	0.000136	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INS—Alzheimer's disease	3.06e-05	0.000135	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	3.01e-05	0.000133	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	2.96e-05	0.00013	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.95e-05	0.00013	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.93e-05	0.000129	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	2.9e-05	0.000128	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	2.89e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	2.89e-05	0.000127	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.88e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	2.86e-05	0.000126	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.84e-05	0.000125	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.77e-05	0.000122	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	2.76e-05	0.000121	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—F2—Alzheimer's disease	2.73e-05	0.00012	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.72e-05	0.000119	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.7e-05	0.000119	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.7e-05	0.000119	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	2.68e-05	0.000118	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.68e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	2.67e-05	0.000117	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.64e-05	0.000116	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.51e-05	0.00011	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	2.5e-05	0.00011	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	2.48e-05	0.000109	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	2.47e-05	0.000109	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	2.43e-05	0.000107	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	2.39e-05	0.000105	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.37e-05	0.000104	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.32e-05	0.000102	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.31e-05	0.000102	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.3e-05	0.000101	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.3e-05	0.000101	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.29e-05	0.000101	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	2.28e-05	0.0001	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	2.26e-05	9.97e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.17e-05	9.53e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.11e-05	9.27e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.1e-05	9.22e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.09e-05	9.2e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.98e-05	8.7e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.97e-05	8.66e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.93e-05	8.51e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.9e-05	8.34e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.86e-05	8.17e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.84e-05	8.09e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.83e-05	8.04e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.8e-05	7.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.78e-05	7.81e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.77e-05	7.79e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.76e-05	7.77e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.75e-05	7.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.69e-05	7.44e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.69e-05	7.42e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.62e-05	7.13e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.56e-05	6.87e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.54e-05	6.77e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.51e-05	6.66e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.51e-05	6.64e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.51e-05	6.64e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.49e-05	6.58e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.46e-05	6.43e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.43e-05	6.3e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.34e-05	5.89e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.32e-05	5.82e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.31e-05	5.78e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.29e-05	5.67e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.23e-05	5.43e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.21e-05	5.32e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.18e-05	5.19e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.13e-05	4.97e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.08e-05	4.75e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.03e-05	4.55e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	9.96e-06	4.38e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	6.08e-06	2.67e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.19e-06	2.29e-05	CbGpPWpGaD
